Capital Asset Advisory Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $452K | Buy |
+5,853
| New | +$452K | 0.02% | 179 |
|
2024
Q4 | – | Sell |
-3,623
| Closed | -$248K | – | 317 |
|
2024
Q3 | $248K | Sell |
3,623
-104
| -3% | -$7.13K | 0.01% | 278 |
|
2024
Q2 | $348K | Sell |
3,727
-20
| -0.5% | -$1.87K | 0.02% | 229 |
|
2024
Q1 | $347K | Buy |
3,747
+11
| +0.3% | +$1.02K | 0.02% | 227 |
|
2023
Q4 | $285K | Buy |
3,736
+64
| +2% | +$4.88K | 0.02% | 243 |
|
2023
Q3 | $261K | Sell |
3,672
-25
| -0.7% | -$1.78K | 0.02% | 262 |
|
2023
Q2 | $345K | Sell |
3,697
-24
| -0.6% | -$2.24K | 0.02% | 237 |
|
2023
Q1 | $308K | Sell |
3,721
-339
| -8% | -$28K | 0.02% | 255 |
|
2022
Q4 | $304K | Buy |
+4,060
| New | +$304K | 0.02% | 268 |
|
2022
Q3 | – | Sell |
-5,081
| Closed | -$483K | – | 498 |
|
2022
Q2 | $483K | Buy |
+5,081
| New | +$483K | 0.05% | 233 |
|
2020
Q3 | – | Sell |
-10,470
| Closed | -$803K | – | 569 |
|
2020
Q2 | $803K | Buy |
+10,470
| New | +$803K | 0.17% | 111 |
|
2020
Q1 | – | Sell |
-10,755
| Closed | -$829K | – | 537 |
|
2019
Q4 | $829K | Buy |
10,755
+225
| +2% | +$17.3K | 0.19% | 100 |
|
2019
Q3 | $772K | Sell |
10,530
-90
| -0.8% | -$6.6K | 0.51% | 36 |
|
2019
Q2 | $654K | Hold |
10,620
| – | – | 0.5% | 35 |
|
2019
Q1 | $677K | Hold |
10,620
| – | – | 0.88% | 18 |
|
2018
Q4 | $542K | Sell |
10,620
-45
| -0.4% | -$2.3K | 0.52% | 44 |
|
2018
Q3 | $619K | Sell |
10,665
-150
| -1% | -$8.71K | 0.52% | 45 |
|
2018
Q2 | $525K | Sell |
10,815
-1,275
| -11% | -$61.9K | 0.47% | 46 |
|
2018
Q1 | $562K | Sell |
12,090
-105
| -0.9% | -$4.88K | 0.52% | 48 |
|
2017
Q4 | $458K | Sell |
12,195
-1,935
| -14% | -$72.7K | 0.42% | 63 |
|
2017
Q3 | $515K | Sell |
14,130
-585
| -4% | -$21.3K | 0.47% | 54 |
|
2017
Q2 | $575K | Buy |
+14,715
| New | +$575K | 0.37% | 65 |
|
2016
Q2 | – | Sell |
-15,000
| Closed | -$441K | – | 70 |
|
2016
Q1 | $441K | Buy |
+15,000
| New | +$441K | 0.48% | 45 |
|